EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Characterization of RNA driven structural changes in full length RIG-I leading to its agonism or antagonism

Justyna Sikorska iD, Yan Hou, Paul Chiurazzi, Tony Siu, Gretchen A Baltus, Payal Sheth, David G McLaren, Quang Truong, Craig A Parish, Daniel F Wyss

Nucleic Acids Research · 22.09.2023 · 51 (17) · 9356-9368

DOI: 10.1093/nar/gkad606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 24.07.2023. Verfasst von Justyna Sikorska und 9 weiteren Autor:innen. Beteiligte Einrichtung: Merck & Co., Inc., Rahway, NJ, USA. Hauptthemen laut MEDLINE: Trans-Activators. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Merck Sharp & Dohme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RIG-I (retinoic acid inducible gene-I) can sense subtle differences between endogenous and viral RNA in the cytoplasm, triggering an anti-viral immune response through induction of type I interferons (IFN) and other inflammatory mediators. Multiple crystal and cryo-EM structures of RIG-I suggested a mechanism in which the C-terminal domain (CTD) is responsible for the recognition of viral RNA with a 5′-triphoshate modification, while the CARD domains serve as a trigger for downstream signaling, leading to the induction of type I IFN. However, to date contradicting conclusions have been reached around the role of ATP in the mechanism of the CARD domains ejection from RIG-I’s autoinhibited state. Here we present an application of NMR spectroscopy to investigate changes induced by the binding of 5′-triphosphate and 5′-OH dsRNA, both in the presence and absence of nucleotides, to full length RIG-I with all its methionine residues selectively labeled (Met-[ϵ-13CH3]). With this approach we were able to identify residues on the CTD, helicase domain, and CARDs that served as probes to sense RNA-induced conformational changes in those respective regions. Our results were analyzed in the context of either agonistic or antagonistic RNAs, by and large supporting a mechanism proposed by the Pyle Lab in which CARD release is primarily dependent on the RNA binding event.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trans-ActivatorsDEAD Box Protein 58Interferon Type IProtein Structure, TertiaryRNA, Double-StrandedRNA, ViralSignal Transduction

Substanzen

DEAD Box Protein 58Interferon Type IRNA, Double-StrandedRNA, ViralTrans-Activators

Autor:innen und Institutionen

  • Merck & Co., Inc., Rahway, NJ, USA.

ORCID-Profile: Justyna Sikorska

Förderung

  • Merck Sharp & Dohme

Zitieren

APA

Sikorska, J., Hou, Y., Chiurazzi, P., Siu, T., Baltus, G. A., Sheth, P., McLaren, D. G., Truong, Q., Parish, C. A., & Wyss, D. F. (2023). Characterization of RNA driven structural changes in full length RIG-I leading to its agonism or antagonism. Nucleic Acids Research, 51(17), 9356-9368. https://doi.org/10.1093/nar/gkad606

Vancouver

Sikorska J, Hou Y, Chiurazzi P, Siu T, Baltus GA, Sheth P, et al. Characterization of RNA driven structural changes in full length RIG-I leading to its agonism or antagonism. Nucleic Acids Research. 2023;51(17):9356-9368. doi:10.1093/nar/gkad606

BibTeX
@article{Sikorska2023,
  author = {Sikorska, Justyna and Hou, Yan and Chiurazzi, Paul and Siu, Tony and Baltus, Gretchen A and Sheth, Payal and McLaren, David G and Truong, Quang and Parish, Craig A and Wyss, Daniel F},
  title = {Characterization of RNA driven structural changes in full length RIG-I leading to its agonism or antagonism},
  journal = {Nucleic Acids Research},
  year = {2023},
  volume = {51},
  number = {17},
  pages = {9356--9368},
  doi = {10.1093/nar/gkad606}
}
Kostenlos starten →